Elsevier Science, Inc.

SHERPA: Unknown

People

  1. Castro-Malaspina
    Castro-Malaspina
  2. Giralt
    Giralt
  3. O'Reilly
    O'Reilly
  4. Papadopoulos
    Papadopoulos
  5. Young
    Young
  6. Landau
    Landau
  7. Perales
    Perales
  8. Shah
    Shah
  9. Jakubowski
    Jakubowski
  10. Kernan
    Kernan

Groups

  1. Bone Marrow Transplant (48)
  2. Center for Hematologic Malignancies (48)
  3. Department of Medicine (48)
  4. Hematologic Malignancies, Division of (46)
  5. Survivorship Research (19)
  6. GSK Faculty (15)
  7. Sloan Kettering Institute Faculty (15)
  8. Pediatrics, Department of (12)
  9. Tow Center for Developmental Oncology (TCDO) (12)
  10. Immunology Program Faculty (11)
Search Within
  1. "Bone Marrow Transplant"
Formats
  1. Meeting Abstract (26)
  2. Journal Article (19)
  3. Review (2)
  4. Guidelines (1)
Groups
  1. Bone Marrow Transplant (48)
  2. Center for Hematologic Malignancies (48)
  3. Department of Medicine (48)
  4. Hematologic Malignancies, Division of (46)
  5. Survivorship Research (19)
  6. GSK Faculty (15)

More Groups

People
  1. Hugo Castro-Malaspina (11)
  2. Sergio Giralt (11)
  3. Esperanza Papadopoulos (9)
  4. Richard O'Reilly (9)
  5. Barrett Childs (7)
  6. James Young (7)

More People

Years
  1. 2024 (2)
  2. 2023 (2)
  3. 2022 (1)
  4. 2021 (4)
  5. 2020 (4)
  6. 2019 (4)

More Years

Publications
  1. Experimental Hematology (16)
  2. The Lancet Haematology (8)
  3. Lancet Oncology (5)
  4. Journal of the American College of Cardiology (4)
  5. Value in Health (4)
  6. International Journal of Infectious Diseases (2)

More Publications

Results (48)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Health-related quality of life in patients with triple-class exposed relapsed and refractory multiple myeloma treated with idecabtagene vicleucel or standard regimens: patient-reported outcomes from the phase 3, randomised, open-label KarMMa-3 clinical trial
    Journal Article

    Delforge, M.; Patel, K.; Eliason, L.; Dhanda, D.; Shi, L.; Guo, S.; Marshall, T. S.; Arnulf, B.; Cavo, M.; Nooka, A.; more...
    The Lancet Haematology (2024)

    Fulltext@MSK | Save
  • Indication and management of allogeneic haematopoietic stem-cell transplantation in myelofibrosis: Updated recommendations by the EBMT/ELN International Working Group
    Review

    Kröger, N.; Bacigalupo, A.; Barbui, T.; Ditschkowski, M.; Gagelmann, N.; Griesshammer, M.; Gupta, V.; Hamad, N.; Harrison, C.; Hernandez-Boluda, J. C.; more...
    The Lancet Haematology (2024)

    Fulltext@MSK | Save
  • Residual mutant hematopoietic stem cells drives post-transplant relapse of the myelodysplastic syndromes
    Meeting Abstract

    Kroger, B.; Son, A.; Huang, Y.; Patel, P.; Afrough, A.; Kaur, G.; Anderson, L.; Awan, F.; Ramakrishnan, P.; Verma, K.; more...
    Experimental Hematology (2023)

    Fulltext@MSK | Save
  • Real-world treatment patterns, healthcare resource utilization (HRU) and costs for relapsed/refractory (R/R) large B-cell lymphoma (LBCL): Chimeric antigen receptor T-cell (CAR T) and monoclonal antibodies (MAB) therapies
    Meeting Abstract

    Feng, C.; Murphy, L.; Engel-Nitz, N.; Nguyen, A.; Patel, A.; DuCharme, M.; Fu, C.; Shah, G.
    Value in Health (2023)

    Fulltext@MSK | Save
  • Myocardial composition in light-chain cardiac amyloidosis more than 1 year after successful therapy
    Journal Article

    Cuddy, S. A. M.; Jerosch-Herold, M.; Falk, R. H.; Foley Kijewski, M.; Singh, V.; Ruberg, F. L.; Sanchorawala, V.; Landau, H.; Maurer, M. S.; Yee, A. J.; more...
    JACC: Cardiovascular Imaging (2022)

    Fulltext@MSK | Save
  • Adverse cardiovascular and pulmonary events associated with chimeric antigen receptor T-cell therapy
    Journal Article

    Goldman, A.; Maor, E.; Bomze, D.; Liu, J. E.; Herrmann, J.; Fein, J.; Steingart, R. M.; Mahmood, S. S.; Schaffer, W. L.; Perales, M. A.; more...
    Journal of the American College of Cardiology (2021)

    Fulltext@MSK | Save
  • Dynamics of minimal residual disease in patients with multiple myeloma on continuous lenalidomide maintenance: A single-arm, single-centre, phase 2 trial
    Journal Article

    Diamond, B.; Korde, N.; Lesokhin, A. M.; Smith, E. L.; Shah, U.; Mailankody, S.; Hultcrantz, M.; Hassoun, H.; Lu, S. X.; Tan, C.; more...
    The Lancet Haematology (2021)

    Fulltext@MSK | Save
  • Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: An observational cohort study
    Journal Article

    Sharma, A.; Bhatt, N. S.; St Martin, A.; Abid, M. B.; Bloomquist, J.; Chemaly, R. F.; Dandoy, C.; Gauthier, J.; Gowda, L.; Perales, M. A.; more...
    The Lancet Haematology (2021)

    Fulltext@MSK | Save
  • Development and validation of a disease risk stratification system for patients with haematological malignancies: A retrospective cohort study of the European Society for Blood and Marrow Transplantation registry
    Journal Article

    Shouval, R.; Fein, J. A.; Labopin, M.; Cho, C.; Bazarbachi, A.; Baron, F.; Bug, G.; Ciceri, F.; Corbacioglu, S.; Galimard, J. E.; more...
    The Lancet Haematology (2021)

    Fulltext@MSK | Save
  • Improved quantification of cardiac amyloid burden in systemic light chain amyloidosis: Redefining early disease?
    Journal Article

    Cuddy, S. A. M.; Bravo, P. E.; Falk, R. H.; El-Sady, S.; Kijewski, M. F.; Park, M. A.; Ruberg, F. L.; Sanchorawala, V.; Landau, H.; Yee, A. J.; more...
    JACC: Cardiovascular Imaging (2020)

    Fulltext@MSK | Save